Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date Filed: October 29, 2015
Reporting Period: Third quarter ended September 30, 2015
Context: The filing serves to distribute an Investor News release containing third-quarter 2015 financial results. The document explicitly states that the attached Investor News (Exhibit 99.1) contains the detailed financial data and non-GAAP reconciliations.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Investor News (Exhibit 99.1), which is referenced but not included in the input text.
- Revenue, Profit, Cash Flow: Not provided in this text.
- Margins, Debt, Liquidity: Not provided in this text.
- Non-GAAP Measures Referenced: The filing notes the use of EBITDA (operating income excluding interest, taxes, depreciation, and amortization) and free cash flow to supplement GAAP results.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that the attached Investor News includes third-quarter 2015 consolidated financial results and reconciliations for non-GAAP measures to ensure consistency with prior periods.
Guidance, Outlook, and Risks
Management Commentary: Management states that non-GAAP measures (EBITDA and free cash flow) are provided to enhance the user's understanding of current financial performance and future prospects. They emphasize that these measures should not be used as a substitute for GAAP financial measures.
Regulatory Note: The filing clarifies that the attached Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this Form 6-K.
Investor Verification Checklist
- Verify the specific revenue and profit figures in the attached Investor News (Exhibit 99.1), as they are absent from this summary text.
- Review the reconciliation of non-GAAP measures (EBITDA and free cash flow) to GAAP measures in the attached exhibit.
- Confirm the full text of the third-quarter 2015 results to assess material changes and year-over-year performance.